Searched for
JAPANESE PHARMA MARKET
Japanese investors are looking beyond China... India is key alternative: Tsutomu Takemura, Senior MD, NomuraIndia is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- GIFT Nifty jumps 110 points on Iran-US peace talk hopes; Nifty seen reclaiming 24K on MondayGIFT Nifty surged 110 points on hopes of renewed Iran-US peace talks, boosting sentiment after weak markets. Positive global cues could hel...
- Global Markets | Japan's Nikkei climbs as AI optimism outweighs Mideast concernsJapanese stocks surged Monday, nearing a historic peak, fueled by booming AI sector enthusiasm that overshadowed Middle East tensions. Majo...
- The yen connection: 4 Indian pharma stocks which benefit from the strength of Japanese yen with an upside potential of up to 15%Every event in the currency market has a twin impact, while some lose but there are others which also gain. But given the mayhem on the str...
- Sun Pharma arm launches plaque psoriasis treatment drug in JapanIn a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection...
- Japanese companies make cautious return to Indian pharma marketOther drug companies whose acquisition went southwards included Mitsui & Co, which acquired a significant stake in Arch Pharma.
- Biocon's partner firm launches diabetes product in JapanIn March this year, Biocon received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine.
- Sun Pharma gains nearly 3% as co buys 14 brands from Novartis"This acquisition marks Sun Pharma's foray into the Japanese prescription market and provides us an opportunity to build a larger product p...
- Sun Pharma acquires 14 Novartis brands in Japan for $293 millionThe acquired brands will be marketed by a reliable and established local marketing partner under the Sun Pharma label.
- Deal with Ranbaxy: Should Daiichi Sankyo have followed the Nemawashi way?A core value of Japanese business is trust. And this is where Daiichi Sankyo’s Ranbaxy problem may start to hurt India-Japan ties.
- Fujifilm, Dr Reddy’s call off Japanese JV pactDr. Reddy's Laboratories and Japan's Fujifilm Corp have decided to terminate joint venture partnership they entered into in July 2011.
- Japanese pharma cos keen on tie-ups with Indian companiesA delegation of pharmaceutical firms from Japan's Toyama prefecture today indicated that Japanese companies are keen to collaborate with In...
- India likely to press for more access to Japanese pharma marketThe CEPA between India and Japan came into effect from August 1 2011. Both the sides expects that it would boost bilateral trade.
- Japan may open up to Indian genericsJapan has veered round to considering India’s demand to open up its over $100-billion pharmaceutical market to Indian generic, or off-paten...
- Japan's Daiichi to set up manufacturing, research unitThe $8-billion Daiichi Sankyo Company, Japan’s second-largest pharma company, is in the process of setting up a full-fledged manufacturing ...
- Lupin makes a leap into Japanese pharma marketLupin’s acquisition in Japan gives it a foothold in a large pharmaceutical market with relatively low generic penetration. Japan is the wor...
- Zydus scouts for partners in Land of Rising SunThe company is in talks with 2-3 pharma companies and has earmarked an investment of about $25 million for its expansion plans in Japan.
- Sun Pharma scouts for supply tie-ups in EuropeMumbai-based Sun Pharma is about to give its bulk drug business a shot in the arm - it’s scouting for tie-ups in Europe to supply a range o...
Load More
